A CAR T-cell therapy targeting glioblastoma improved tumor control and survival in mice when given before surgery rather than afterward, according to a new study.
Glioma
Safusidenib, an experimental oral treatment for people with gliomas carrying IDH1 gene mutations, has received fast-track designation from…
Treatments using gamma delta T-cells, a type of immune cell, hold promise for treating glioblastoma, scientists said, though they added that much more research is…
July 15 marks the eighth annual Glioblastoma Awareness Day in the U.S., and advocates are calling for continued efforts to advance research and improve life…
A new arm of a clinical trial has begun testing Knoa Pharma‘s experimental therapy tinostamustine in people with glioblastoma, an aggressive form of…
Starting the electrical therapy Optune Gio during radiation therapy and chemotherapy, rather than after it as indicated, did not extend survival in people with newly…
NeuExcell Therapeutics‘ investigational gene therapy, NXL-004, showed a potential survival benefit in a small group of people with recurrent malignant glioma in an…
Preliminary Phase 1 trial data show that uTREAT, Curasight’s experimental targeted cancer therapy, was safely delivered to aggressive solid brain tumors and reached estimated…
Add-on treatment with DeltEx DRI, a cell therapy being developed by In8bio, may help prolong survival in people with glioblastoma, an aggressive form of…
An experimental therapy designed to mimic vitamin B12 and deliver a toxic molecule to tumor cells showed promise as a potential treatment for an aggressive…
Recent Posts
- A myeloma patient weighs wine warnings, food recalls, and cancer risks
- FDA OKs therapy’s testing in myeloma patients – but trial awaits funding
- Targeting inflammation may help control polycythemia vera
- The letters I never send and the words I write but never share
- AI CAR T-cell therapy bests approved treatment in mouse study